PRMT5 and hepatocellular carcinoma: PRMT5 was overexpressed in multiple tumor types including leukemia, lymphoma, lung27, colorectal and breast cancer as well as in HCC and it resulted in increased symmetrical dimethylation on H2A and H4 R3-motifs35.